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We present a case of a 17 year old male who presented with altered mental status and
worsening hallucinations. Past medical history includes PTSD, ADHD, and pineal gland
germinoma status post radiofrequency ablation.
Presentation was remarkable for slow, dysarthric speech, mental disorientation, and
delayed movements upon simple commands. Otherwise, vitals, baseline labs, imaging
(Brain MRI), and diagnostics (EEG) were unremarkable.
A multidisciplinary team decided to initially undergo psychiatric therapeutic intervention,
focused on benzodiazepines and anti-psychotics, however patient’s status worsened,
demonstrating catatonia, dystonia, and explosive agitation. Further laboratory
investigation ruled out electrolyte disturbances, uremia/hepatic encephalopathy, thyroid
storm, drug overdose/withdrawal, eventually settling on a working diagnosis of catatonic
depression.
Given his deteriorating mental status throughout admission and prior oncologic history, a
lumbar puncture was performed to rule out other causes of encephalopathy, with CSF
studies remarkable for the presence of NMDA encephalitis autoantibodies, most likely
sequelae from his existing pineal gland germinoma.
Anti-NMDA receptor encephalitis is an autoimmune disease associated with antibodies
against N-methyl-D-aspartate (NDMA) receptors, which control electrical impulses in the
brain. These autoantibodies can variably be associated with tumors and possibly
responsive to immunotherapy. Initial treatment consisted of intravenous immunoglobulin
(IVIG), methylprednisolone and therapeutic plasma exchange. After minimal success,
patient received rituximab and sirolimus, which resulted in improved psychomotor
symptoms.
Diagnosing Anti-NMDA receptor encephalitis can be quite challenging, particularly with
its variable presentation in the setting of prior psychiatric diagnoses. Classically, AntiNMDA receptor encephalitis demonstrates hyperkinetic movements (e.g. dystonia,
dyskinesia, chorea, seizures); however, catatonic movements do occur, and can be a
severe and life-threatening state. Being cognizant of the overlapping psychiatric and
psychomotor symptoms, including catatonic features, can prompt the clinician to suspect
and rule out Anti-NMDA encephalitis prior to settling on a primary psychiatric diagnosis.

